S'abonner

Determining Real Change in Conditioned Pain Modulation: A Repeated Measures Study in Healthy Volunteers - 01/09/20

Doi : 10.1016/j.jpain.2019.09.010 
Donna L. Kennedy , 1, , Harriet I. Kemp , 1, Chenxian Wu , Deborah A. Ridout , Andrew S.C. Rice
 Pain Research Group, Department of Surgery & Cancer, Imperial College London, United Kingdom 
 Imperial College London School of Medicine, United Kingdom 
 Population, Policy and Practice Programme, UCL Great Ormond Street Institute of Child Health, University College London, United Kingdom 

⁎⁎Address reprint requests to Donna L. Kennedy, PhD, Pain Research Group, Department of Surgery & Cancer, Imperial College London, Chelsea & Westminster Hospital Campus, 369 Fulham Road, London SW10 9NH, UK.Pain Research GroupDepartment of Surgery & CancerImperial College LondonChelsea & Westminster Hospital Campus369 Fulham RoadLondonSW10 9NHUK

Highlights

Reporting in conditioned pain modulation (CPM) is not standardized and does not consider measurement error.
A distribution-based approach enables the identification of “real” change in CPM.
The proportion of CPM inhibitors and facilitators is paradigm dependent.
Intersession CPM response is not consistent in healthy subjects.
Standardization in reporting will underpin emerging clinical utility of CPM.

Le texte complet de cet article est disponible en PDF.

Abstract

Conditioned pain modulation (CPM) is a potentially useful biomarker in pain populations; however, a statistically robust interpretation of change scores is required. Currently, reporting of CPM does not consider measurement error. Hence, the magnitude of change representing a “true” CPM effect is unknown. This study determined the standard error of measurement (SEM) and proportion of healthy participants showing a “true” CPM effect with a standard CPM paradigm. Fifty healthy volunteers participated in an intersession reliability study using pressure pain threshold (PPT) test stimulus and contact heat, cold water, and sham conditioning stimuli. Baseline PPTs were used to calculate SEM and >±2 × SEM to determine CPM effect. SEM for PPT was .21 kg/cm2. An inhibitory CPM effect (>+2 SEM) was elicited in 59% of subjects in response to cold stimulus; in 44% to heat. Intrasession and intersession reliability of within-subject CPM response was poor (kappa coefficient <.36). Measurement error is important in determining CPM effect and change over time. Even when using reliable test stimuli, and incorporating measures to limit bias and error, CPM intersession reliability was fair and demonstrated a large degree of within-subject variation. Determining “true” change in CPM will underpin future interrogations of intraindividual differences in CPM.

Perspective

This study used a distribution-based statistical approach to identify real change in CPM, based on the SEM for the test stimulus. Healthy volunteers demonstrate substantial within-subject variation; CPM effect was paradigm dependent at intrasession testing and unstable to the same paradigm at intersession testing.

Le texte complet de cet article est disponible en PDF.

Key Words : Conditioned pain modulation, pressure pain threshold, measurement error, intersession test stability


Plan


 Disclosures: H.I.K was funded by a European Commission, NeuroPain FP7 Grant EC (#2013-602891). D.L.K.’s work was funded by a National Institute for Health Research (NIHR) and Health Education England (HEE) Clinical Doctoral Research Fellowship (CDRF 2013-04-009). D.R. has received financial support from the NIHR and HEE for her contribution to this work. Professor A.S.C.R. received financial support from DOLORisk, a European Union Horizon 2020 research and innovation programme (grant 633491) for his contribution to this manuscript. Study sponsors provided financial support for the conduct and reporting of this research, they did not contribute to study design; nor collection, analysis or interpretation of data; in the writing of this report; nor in the decision to submit the article for publication.
 Conflict of Interests: H.I.K., D.L.K., C.W., D.A.R.—none declared; A.S.C.R.—conflicts of interest occurring in last 24 months: • Orion Pharma funding; • Consultancy and advisory board work for Imperial College Consultants including remunerated work for: Pharmanovo, Galapagos, Toray, Quartet, Lateral, Novartis, Pharmaleads, Orion, Asahi Kasei & Theranexis; • Owner of share options in Spinifex Pharmaceuticals from which personal benefit accrued upon the acquisition of Spinifex by Novartis in July 2015 and from which future milestone payments may occur. Inventor on patents; • A.S.C.R., Vandevoorde S. and Lambert D.M. Methods using N-(2-propenyl) hexadecanamide and related amides to relieve pain. WO 2005/079771; • Okuse K. et al Methods of treating pain by inhibition of vgf activity EP13702262.0/ WO2013 110945.


© 2019  United States Association for the Study of Pain, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 21 - N° 5-6

P. 708-721 - mai 2020 Retour au numéro
Article précédent Article précédent
  • Synchronous Stimulation With Light and Heat Induces Body Ownership and Reduces Pain Perception
  • Larissa Cordier, Xaver Fuchs, Stephan Herpertz, Jörg Trojan, Martin Diers
| Article suivant Article suivant
  • Short- and Long-Term Effects of Cannabis on Headache and Migraine
  • Carrie Cuttler, Alexander Spradlin, Michael J. Cleveland, Rebecca M. Craft

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.